DAGCO Inc’s CVS Health CVS Stock Holding History

DAGCO Inc’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-9	Closed	-$566	–	109
2024 Q3	$566	Hold	9	–	–	﹤0.01%	219
2024 Q2	$532	Sell	9 -700	-99%	-$43.8K	﹤0.01%	219
2024 Q1	$56.5K	Sell	709 -1,972	-74%	-$151K	0.03%	117
2023 Q4	$212K	Buy	+2,681	New	+$191K	0.19%	57
2021 Q2	–	Sell	-3,059	Closed	-$230K	–	108
2021 Q1	$230K	Sell	3,059 -1,150	-27%	-$83.8K	0.11%	103
2020 Q4	$287K	Sell	4,209 -625	-13%	-$40.7K	0.16%	97
2020 Q3	$282K	Sell	4,834 -1,226	-20%	-$76.3K	0.19%	90
2020 Q2	$394K	Sell	6,060 -700	-10%	-$44.1K	0.4%	67
2020 Q1	$401K	Sell	6,760 -200	-3%	-$13.4K	0.44%	66
2019 Q4	$517K	Sell	6,960 -100	-1%	-$7.02K	0.46%	70
2019 Q3	$445K	Sell	7,060 -441	-6%	-$26.1K	0.45%	70
2019 Q2	$409K	Sell	7,501 -1,510	-17%	-$81.3K	0.43%	71
2019 Q1	$486K	Sell	9,011 -522	-5%	-$32.2K	0.52%	68
2018 Q4	$625K	Buy	+9,533	New	+$712K	0.78%	53

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

DAGCO Inc's CVS Position: Q4 2024 in Review

DAGCO Inc sold out of CVS Health (CVS) in Q4 2024, closing a stake of 9 shares — an estimated $566 sold.

DAGCO Inc first reported a position in CVS in Q4 2018 and held it in 14 quarters. The position peaked at $625K in Q4 2018. 1,669 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

DAGCO Inc reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
DAGCO Inc sold 9 CVS Health shares in Q4 2024, an estimated $566.
DAGCO Inc first reported a position in CVS Health in Q4 2018 and held it in 14 quarters.
DAGCO Inc's CVS Health position peaked at $625K in Q4 2018.
1,669 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on DAGCO Inc's 13F filing for Q4 2024, filed 13 Feb 2025.